Skip to content
10-Q

Quarterly Report

Acrivon Therapeutics, Inc. ACRV

0000950170-25-108054

← back to feed
Filed
Aug 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 8, 2025 31.46M sh
Shares Diluted Q2 2025 · Jun 30, 2025 38.46M sh
Shares Diluted Q2 2025 · Jun 30, 2025 38.41M sh
Shares Diluted Q2 2025 · Jun 30, 2024 36.13M sh
Shares Diluted Q2 2025 · Jun 30, 2024 29.36M sh
Capex Q2 2025 · Jun 30, 2025 $551K
Capex Q2 2025 · Jun 30, 2024 $952K
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$36.15M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$30.99M
Short Term Investments Q2 2025 · Jun 30, 2025 $95.53M
Short Term Investments Q2 2025 · Dec 31, 2024 $139.66M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $41.9M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $39.82M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $46.01M
Stockholders Equity Q2 2025 · Jun 30, 2025 $143.04M
Stockholders Equity Q2 2025 · Mar 31, 2025 $160.39M
Stockholders Equity Q2 2025 · Dec 31, 2024 $176.79M
Stockholders Equity Q2 2025 · Jun 30, 2024 $216.06M
Stockholders Equity Q2 2025 · Mar 31, 2024 $107.98M
Stockholders Equity Q2 2025 · Dec 31, 2023 $121.2M
Current Liabilities Q2 2025 · Jun 30, 2025 $13.43M
Current Liabilities Q2 2025 · Dec 31, 2024 $17.21M
Total Liabilities Q2 2025 · Jun 30, 2025 $15.55M
Total Liabilities Q2 2025 · Dec 31, 2024 $19.8M
Current Assets Q2 2025 · Jun 30, 2025 $138.41M
Current Assets Q2 2025 · Dec 31, 2024 $181.63M
Total Assets Q2 2025 · Jun 30, 2025 $158.58M
Total Assets Q2 2025 · Dec 31, 2024 $196.59M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.55
Eps Diluted Q2 2025 · Jun 30, 2025 −$1.06
Eps Diluted Q2 2025 · Jun 30, 2024 −$0.52
Eps Diluted Q2 2025 · Jun 30, 2024 −$1.20
Eps Basic Q2 2025 · Jun 30, 2025 −$0.55
Eps Basic Q2 2025 · Jun 30, 2025 −$1.06
Eps Basic Q2 2025 · Jun 30, 2024 −$0.52
Eps Basic Q2 2025 · Jun 30, 2024 −$1.20
Sga Expense Q2 2025 · Jun 30, 2025 $6.47M
Sga Expense Q2 2025 · Jun 30, 2025 $12.72M
Sga Expense Q2 2025 · Jun 30, 2024 $6.41M
Sga Expense Q2 2025 · Jun 30, 2024 $12.61M
Rd Expense Q2 2025 · Jun 30, 2025 $16.18M
Rd Expense Q2 2025 · Jun 30, 2025 $31.6M
Rd Expense Q2 2025 · Jun 30, 2024 $15.03M
Rd Expense Q2 2025 · Jun 30, 2024 $26.5M
Net Income Q2 2025 · Jun 30, 2025 −$21.01M
Net Income Q2 2025 · Jun 30, 2025 −$40.69M
Net Income Q2 2025 · Mar 31, 2025 −$19.68M
Net Income Q2 2025 · Jun 30, 2024 −$18.8M
Net Income Q2 2025 · Jun 30, 2024 −$35.28M
Net Income Q2 2025 · Mar 31, 2024 −$16.49M
Operating Income Q2 2025 · Jun 30, 2025 −$22.65M
Operating Income Q2 2025 · Jun 30, 2025 −$44.31M
Operating Income Q2 2025 · Jun 30, 2024 −$21.44M
Operating Income Q2 2025 · Jun 30, 2024 −$39.11M